Aller au contenu principal
Profil bibliographique

Gianmarco Annibali

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

56Publications signalées
711Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Coronary Interventions and DiagnosticsCardiac Valve Diseases and TreatmentsAntiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction ResearchCardiac Imaging and Diagnostics

Les publications récentes

Accès ouvert 2026 article OpenAlex

Care improvement by introduction of a nurse-led structured pathway in patients undergoing transcatheter aortic valve replacement: insights from a multicentre study

D D'amario, Luca Cumitini, Gianmarco Annibali, Vincenzo Galiffa et autres

Abstract Background With the expanding use of transcatheter aortic valve replacement (TAVR), optimizing peri-procedural pathways to improve efficiency while maintaining safety is a clinical priority. Nurse-led structured pathways may standardize care and reduce resource utilization, but real-world data remain limited. Aims To …

us, it (code pays fourni par la source)

0 citations European Heart Journal - Valvular and Structural Heart Disease
2025 article OpenAlex

Management of Acurate Neo 2 Valve Protrusion Into the Left Ventricle

Giorgio Quadri, Innocenzo Scrocca, Gianmarco Annibali, Giuseppe Musumeci

We report the case of an 81-year-old woman with severe aortic stenosis and moderate aortic regurgitation who underwent transcatheter aortic valve implantation (TAVR) with an Acurate Neo 2 valve. During the procedure, the valve protruded into the left ventricle, rendering simple retrieval …

it (code pays fourni par la source)

0 citations Catheterization and Cardiovascular Interventions
2025 article OpenAlex

EARLY USE OF TRIPLE LIPID LOWERING THERAPY IN ACS PATIENTS IN DIFFERENT HOSPITALS

Brunella Demichelis, Fabrizio Delnevo, Ross M. Fasano, I Radano et autres

Abstract Background and Aims We evaluated the feasibility of an early triple lipid lowering therapy (LLT) with PCSK9 inhibitors in patients with acute coronary syndromes (ACS). Methods In this multicenter experience, we consecutively enrolled patients with ACS from July 2023 to July …

it (code pays fourni par la source)

1 citation European Heart Journal Supplements
2025 article OpenAlex

LDL CHOLESTEROL IN PATIENTS WITH PERIPHERAL ARTERY DISEASE: A REAL WORD REGISTRY

Fabrizio Delnevo, I Radano, C De Rosa, Silvia Muccioli et autres

Abstract Aim Low–density lipoprotein (LDL) cholesterol is a modifiable risk factor for cardiovascular disease and peripheral arteriopathy. Our aim is to present a real world analysis of lipid profile and lipid–lowering therapy in patients admitted to our vascular surgery department, for invasive …

it (code pays fourni par la source)

0 citations European Heart Journal Supplements
2024 article OpenAlex

A REAL–WORLD PROTOCOL OF EARLY USE OF TRIPLE LIPID LOWERING THERAPY WITH I–PCSK9

Brunella Demichelis, Massimo Giammaria, Gianmarco Annibali, C De Rosa et autres

Abstract Aim We evaluated the feasibility of an early triple lipid lowering therapy (LLT) with PCSK9 inhibitors in patients with acute coronary syndromes (ACS). Methods In this multicenter experience, we consecutively enrolled ACS patients from July to November 2023. The prescribed LLT …

it (code pays fourni par la source)

0 citations European Heart Journal Supplements

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.